Clinical Trial Update: Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bortezomib with chemotherapy in lymphoid malignancies undergoing stem cell transplantation; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cd20-positive Lymphoid Malignancies
• Hematopoietic and Lymphoid Neoplasms
• Lymphoid Neoplasms
• Lymphoma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: CD20 Positive, Hematopoietic and Lymphoid Cell Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2019-08-13